Tamara Clark, MHS

Clinical Trials Coordinator

Affiliation: MU-UCSF

E-mail Address:  tclark@medsfgh.ucsf.edu

 

tamara

Professional Interests:
Research on the epidemiology of infectious diseases (HIV, TB and malaria) and improved health care in resource-limited environments.

 

Current Main Activities:
Project manager supporting UCSF investigator-led studies conducted at MU-UCSF Research Collaboration in Uganda including:

Children with HIV and malaria project (CHAMP)
Longitudinal comparison of combination antimalarial therapy (U01)
Tororo Child Cohort (TCC) study
Malaria surveillance project (UMSP)
Pharmacokinetics studies of antimalarials in children
Prevalence of Placental Malaria among women in Tororo
Novel strategies to prevent malaria and improve HIV outcomes (PO1)

 

Education and Training:
University of Iowa; Iowa City, Iowa
      Bachelor of Arts (BA) of Biology and Psychology, May 1996

Johns Hopkins School of Hygiene and Public Health; Baltimore, Maryland
      Department of International Health, Disease Prevention and Control Division
      Master of Health Science (MHS), May 2000

 

Publications:

  • Clark TD, Greenhouse B, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C, Staedke SG, Seto E, Kamya MR, Rosenthal PJ, Dorsey G. Factors Determining the Heterogeneity of Malaria Incidence in Children in Kampala, Uganda. J Infect Dis. 2008 Aug 1;198(3):393-400.

  • Staedke SG, Jagannathan P, Yeka A, Bukirwa H, Banek K, Maiteki-Sebuguzi C, Clark TD, Nzarubara B, Njama-Meya D, Mpimbaza A, Rosenthal PJ, Kamya MR, Wabwire-Mangen F, Dorsey G, Talisuna AO. Monitoring antimalarial safety and tolerability in clinical trials: a case study from Uganda. Malar J. 2008 Jun 11;7(1):107.

  • Maiteki-Sebuguzi C, Jagannathan P, Yau VM, Clark TD, Njama-Meya D, Nzarubara B, Talisuna AO, Kamya MR, Rosenthal PJ, Dorsey G, Staedke SG. Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children. Malar J. 2008 Jun 11;7(1):106.

  • Semba RD, Kumwenda J, Zijlstra E, Ricks MO, vanLettow M, Whalen C, Clark TD, Jorgensen L, Kohler J, Kuwenda N, Taha TE, Harries A. Micronutrient supplements and mortality of HIV-infected adults with pulmonary TB: a controlled clinical trial Int J Tuberc Lung Dis. 2007 Aug; 11(8)854-9.

  • Dorsey G, Staedke S, Clark TD, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C, Dokomajilar C, Kamya MR, Rosenthal PJ. Combination therapy for the treatment of uncomplicated falciparum malaria in a cohort of Ugandan children: A longitudinal randomized trial. JAMA. 2007 May 23; 297(20): 2210-2219.

  • Njama-Meya D, Clark TD, Nzarubara B, Staedke S, Kamya MR, Dorsey G. Treatment of malaria restricted to laboratory-confirmed cases: a prospective cohort study in Ugandan children. Malar J. 2007 Jan 21:6:7.

  • Davis JC, Clark TD, Kemble SK, Talemwa N, Njama-Meya D, Staedke SG, Dorsey G. Longitudinal study of urban malaria in a cohort of Ugandan children: description of study site, census and recruitment. Malar J. 2006 Mar 21:5(1):18.

  • Semba RD, Ndugwa C, Perry RT, Clark TD, Jackson JB, Melikian G, Tielsch J, Mmiro F. Effect of periodic vitamin A supplementation on mortality and morbidity of human immunodeficiency virus-infected children in Uganda. Nutrition. 2005 Jan 21(1): 25-31.

  • van Lettow M, Harries AD, Kumwenda JJ, Zijlstra EE, Clark TD, Taha TE, Semba RD. Micronutrient malnutrition and wasting in adults with pulmonary tuberculosis with and without HIV co-infection in Malawi. BMC Infect Dis. 2004 Dec 21;4(1):61.

  • Kang’ombe C, Harries AD, Ito K, Clark T, Nyienda TE, Aldis W, Semba RD, Salaniponi FM. Long-term outcome in patients registered with tuberculosis in Zomba, Malawi: mortality at 7 years according to initial HIV status and type of TB. Int J Tuberc Lung Dis. 2004 Jul;8(7):829-36.

  • Clark TD, Mmiro F, Ndugwa C, Perry RT, Jackson JB, Melikian G, Semba RD. Risk factors and cumulative incidence of anaemia among Human Immunodeficiency Virus infected children in Uganda. Ann Trop Paediatr. 2002 Mar;22(1):11-7.

  • Clark TD, Semba RD. Iron supplementation during human immunodeficiency virus infection: a double-edged sword? Med Hypotheses. 2001 Oct;57(4):476-9.